Evidence map›Paper›PMID 37265674›Full record

ArticleBulletin of the World Health Organization2023

Supply-chain factors and antimicrobial stewardship.

Nduta Kamere, Victoria Rutter, Derick Munkombwe, Dorothy Atieno Aywak, Eva Prosper Muro, Felix Kaminyoghe, Kalidi Rajab, Mashood Oluku Lawal, Naomi Muriithi, Ndinda Kusu and 4 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nduta KamereCommonwealth Pharmacists Association, London, England.
Victoria RutterCommonwealth Pharmacists Association, London, England.
Derick MunkombweDepartment of Pharmacy, University of Zambia, Lusaka, Zambia.
Dorothy Atieno AywakDivision of Pharmaceutical Services, Kenyatta National Hospital, Nairobi, Kenya.
Eva Prosper MuroKilimanjaro Christian Medical University College, Kilimanjaro, United Republic of Tanzania.
Felix KaminyoghePharmaceutical Society of Malawi, Lilongwe, Malawi.
Kalidi RajabMakerere University Pharmacy Department, Kampala, Uganda.
Mashood Oluku LawalPharmaceutical Society of Nigeria, Lagos, Nigeria.
Naomi MuriithiHELP Logistics Ltd, Nairobi, Kenya.
Ndinda KusuMedicines, Technologies, and Pharmaceutical Services Program, Management Sciences for Health, Nairobi, Kenya.
Oluwatoyin KarimuNational Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria.
Shuwary Hughric Adekule BarlattDirectorate of Pharmaceutical Services, Freetown, Sierra Leone.
Winnie NambatyaMakerere University Pharmacy Department, Kampala, Uganda.
Diane Ashiru-OredopeCommonwealth Pharmacists Association, London, England.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient and secure supply chains are vital for effective health services worldwide. In low- and middle-income countries, the accessibility, affordability and availability of essential medicines, including antimicrobials, remain challenging. Ineffective supply chains often cause antimicrobial shortages, leading to inappropriate use of alternative agents and increasing the risk of antimicrobial resistance. Shortages, coupled with insecure supply chains, also encourage the infiltration of substandard and falsified medicines, leading to suboptimal treatment and further promoting antimicrobial resistance. Addressing antimicrobial supply-chain issues should be considered a key component of antimicrobial stewardship programmes. We have explored the link between medicine supply chains and antimicrobial use in seven focus countries: Kenya, Malawi, Nigeria, Sierra Leone, Uganda, United Republic of Tanzania and Zambia. We explored country medicine supply-system structures, national medicine supply-chain policy documents and global study reports. Our aim was to develop evidence-based strategies to enhance the effectiveness and efficiency of the medicine supply chains in supporting antimicrobial stewardship efforts. Better management of medical supply chains involves rational selection, quantification, forecasting, procurement, storage, distribution, use and stock management of antimicrobials. Important supply-chain considerations include pooled procurement networks to ensure consistent pricing of quality-assured antimicrobials, and improved resource utilization and information exchange among relevant stakeholders. We propose adaptable recommendations for integrating medicine supply chains as an essential part of antimicrobial stewardship programmes, with a call for action at the local, regional and national levels in low- and middle-income countries.

Indexed as

Antimicrobial StewardshipHumansKenyaNigeriaTanzaniaUganda

Identifiers

PMID37265674
PMCPMC10225941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.